- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
5
Value score of at least 4 focused on companies with a low market cap.
5 companies
Anxo Pharmaceutical
Market Cap: NT$1.1b
A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.
6677
NT$19.55
7D
2.4%
1Y
7.4%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$29.35
7D
0.7%
1Y
7.6%
Winston Medical Supply
Market Cap: NT$1.3b
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.
6817
NT$69.30
7D
-3.5%
1Y
-26.4%
Prince Pharmaceutical
Market Cap: NT$1.1b
Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.
6935
NT$30.35
7D
9.2%
1Y
43.5%
Bioray Biotech
Market Cap: NT$656.8m
Engages in the production, research, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$22.20
7D
-3.9%
1Y
11.3%